BR9206272A - Derivatives of 2- (4-hydroxypiperidine) -1-alkanol, as anti-ischemic agents. - Google Patents

Derivatives of 2- (4-hydroxypiperidine) -1-alkanol, as anti-ischemic agents.

Info

Publication number
BR9206272A
BR9206272A BR9206272A BR9206272A BR9206272A BR 9206272 A BR9206272 A BR 9206272A BR 9206272 A BR9206272 A BR 9206272A BR 9206272 A BR9206272 A BR 9206272A BR 9206272 A BR9206272 A BR 9206272A
Authority
BR
Brazil
Prior art keywords
hydroxypiperidine
alkanol
derivatives
ischemic agents
ischemic
Prior art date
Application number
BR9206272A
Other languages
Portuguese (pt)
Inventor
Welch Willard Mckowan Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9206272A publication Critical patent/BR9206272A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9206272A 1991-07-17 1992-06-19 Derivatives of 2- (4-hydroxypiperidine) -1-alkanol, as anti-ischemic agents. BR9206272A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73157791A 1991-07-17 1991-07-17
PCT/US1992/004973 WO1993002052A1 (en) 1991-07-17 1992-06-19 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents

Publications (1)

Publication Number Publication Date
BR9206272A true BR9206272A (en) 1995-04-11

Family

ID=24940103

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9206272A BR9206272A (en) 1991-07-17 1992-06-19 Derivatives of 2- (4-hydroxypiperidine) -1-alkanol, as anti-ischemic agents.

Country Status (22)

Country Link
EP (1) EP0594729A1 (en)
JP (1) JP2571904B2 (en)
KR (1) KR0165003B1 (en)
CN (1) CN1043759C (en)
AU (1) AU655840B2 (en)
BR (1) BR9206272A (en)
CA (1) CA2113568A1 (en)
CZ (1) CZ284133B6 (en)
EG (1) EG20048A (en)
FI (2) FI940192A (en)
HU (1) HUT70528A (en)
IE (1) IE922311A1 (en)
IL (1) IL102473A (en)
MX (1) MX9204190A (en)
NO (1) NO180445C (en)
NZ (1) NZ243580A (en)
PL (1) PL169884B1 (en)
PT (1) PT100689B (en)
RU (1) RU2065859C1 (en)
TW (1) TW201732B (en)
WO (1) WO1993002052A1 (en)
ZA (1) ZA925306B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
NZ255074A (en) * 1992-10-30 1996-10-28 Pfizer 6-[2-(4-hydroxy-4-(4-substituted phenyl)piperidino)-1-hydroxypropyl]-3,4-dihydro-2(1h)-quinolones
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
WO2000061558A1 (en) * 1999-04-09 2000-10-19 Mochida Pharmaceutical Co., Ltd. Remedies for neuropathic pain
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6362196B1 (en) 1999-10-29 2002-03-26 Merck & Co., Inc. Method to treat pain utilizing benzimidazole NMDA/NR2B antagonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
IL157254A0 (en) 2001-02-23 2004-02-19 Merck & Co Inc N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
WO2002080928A1 (en) 2001-04-03 2002-10-17 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
US7494987B2 (en) 2002-11-25 2009-02-24 Mochida Pharmaceutical Co., Ltd. Agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient
EP1673367A1 (en) * 2003-10-08 2006-06-28 Pfizer, Inc. Fused lactam compounds
TWI409289B (en) 2010-09-02 2013-09-21 Taiwan Union Technology Corp Stable solution of the polymer prepared from n,o-heterocycles and its preparinging method and use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2546166B1 (en) * 1983-05-19 1985-10-25 Synthelabo ENANTIOMERS OF ERYTHRO (BENZYL-4 PIPERIDINO) -2 (HYDROXY-4 OR BENZYLOXY-4 PHENYL) -1 PROPANOL, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2640266B2 (en) * 1988-07-12 1992-07-10 Synthelabo INDOLONES-2, QUINOLEINONES-2, BENZO (B) AZEPINONES-2 AND BENZIMIDAZOLONES-2 DERIVATIVES OF (HYDROXY-1 PIPERIDINYL-2 ALKYL), THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ES2098248T3 (en) * 1989-05-17 1997-05-01 Pfizer DERIVATIVES OF 2-PIPERIDINE-1-ALCANOLS AS ANTI-ISCHEMICAL AGENTS.
BR9106432A (en) * 1990-05-10 1993-05-04 Pfizer NEUROPROTECTIVE INDOLONE AND RELATED DERIVATIVES

Also Published As

Publication number Publication date
KR0165003B1 (en) 1999-01-15
CN1043759C (en) 1999-06-23
IL102473A0 (en) 1993-01-14
FI940192A0 (en) 1994-01-14
NO180445B (en) 1997-01-13
CZ284133B6 (en) 1998-08-12
FI981956A (en) 1998-09-11
NO940144D0 (en) 1994-01-14
HU9400136D0 (en) 1994-05-30
EP0594729A1 (en) 1994-05-04
ZA925306B (en) 1994-01-17
NO940144L (en) 1994-01-14
CN1068566A (en) 1993-02-03
JPH06504293A (en) 1994-05-19
PL169884B1 (en) 1996-09-30
IL102473A (en) 1997-07-13
CZ400892A3 (en) 1994-03-16
EG20048A (en) 1997-03-27
WO1993002052A1 (en) 1993-02-04
FI981956A0 (en) 1998-09-11
AU2322592A (en) 1993-02-23
AU655840B2 (en) 1995-01-12
NO180445C (en) 1997-04-23
HUT70528A (en) 1995-10-30
PT100689A (en) 1993-10-29
IE922311A1 (en) 1993-01-27
JP2571904B2 (en) 1997-01-16
MX9204190A (en) 1993-01-01
CA2113568A1 (en) 1993-02-04
RU2065859C1 (en) 1996-08-27
PT100689B (en) 1999-06-30
FI940192A (en) 1994-01-14
NZ243580A (en) 1994-10-26
TW201732B (en) 1993-03-11

Similar Documents

Publication Publication Date Title
BR9206272A (en) Derivatives of 2- (4-hydroxypiperidine) -1-alkanol, as anti-ischemic agents.
DE59108494D1 (en) 1-H-3-aryl-pyrrolidine-2,4-dione derivatives
NL300035I2 (en) Substituted thiazolidinedione derivatives.
DE69005858T3 (en) Heterocyclic compounds.
MX9204425A (en) QUINAZOLINE DERIVATIVES AS ACETYLCHOLINESTERASE INHIBITORS.
DE68913022D1 (en) Heterocyclic derivatives.
DE59100656D1 (en) Drill chuck.
DE59501802D1 (en) Substituted 1H-3-aryl-pyrrolidine-2,4-dione derivatives
DE59101925D1 (en) Drill chuck.
MX9205678A (en) HETEROARILAMINES AS NEW INHIBITORS OF ACETYLCHOLINESTERASE.
DE69101171D1 (en) Laser drilling.
BR9609849B1 (en) 2- (4-substituted) -benzylamino-2-methyl-propanamide derivatives.
FI932959A (en) KINOXALIN DERIVATIVES, DERAS FRAMSTAELLNING OCH ANVAENDNING I LAEKEMEDEL
FI910033A (en) LAOGMAETTAT, PLASTISKT UNIVERSALFETT MED SPECIELLT HYDROGENERAD DELVIS SMAELTANDE FETTKONPONENT.
DE3854077D1 (en) Piperidine derivatives.
DE69110093D1 (en) Pyrimidine derivatives.
DK101689A (en) 4-SUBSTITUTED PYRAZOLOOE3,4-DAAPYRIMIDINE DERIVATIVES
DE69017383D1 (en) SUBSTITUTED BICYCLOHEPTADION DERIVATIVES.
DE69013131D1 (en) 2- (2-Cyclopropylpyrrolidin-4-ylthio) carbapenem derivatives.
NO922428L (en) Heterocyclic compounds with purifying properties
FI913893A (en) TRICYCLIC HETEROCYCLIC DERIVATIVES.
FI913655A (en) 2- (9-FLUORENONYL) -CARBAPENEM ANTIBACTERIUM FOERENINGAR.
ATE93523T1 (en) 4-(2-PYRIMIDYL)-1-PIPERAZINYL-SUBSTITUTED HETEROCYCLIC CARBONYL DERIVATIVES.
ATE68486T1 (en) 1-((2-FLUOROPHENYL)(4-FLUOROPHENYL)PHENYLMETHYL - 1H-IMIDAZOLE.
DE58907941D1 (en) Substituted 2- (halomethylthio) pyrimidine derivatives.

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal